New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

About 4% of GLP-1 users developed osteoporosis, compared with a little over 3% of nonusers — an increased risk of about 30%. A related condition, osteomalacia, which involves the softening of the ...

The appetite-suppressing drugs decrease a person's intake of food and nutrients, which can impact bone health and lead to ...

This content was originally produced for audio. Certain elements, such as tone, sound effects, and music, may not fully capture the intended experience in textual representation. Therefore, the ...